3-(''p''-Fluorobenzoyloxy)tropane

3-(p-Fluorobenzoyloxy)tropane

Clinical data
Routes of administration	insufflated
Legal status
Legal status	DE: Anlage II (Authorized trade only, not prescriptible)
Identifiers
IUPAC name (1R,5S)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-fluorobenzoate
CAS Number	172883-97-5 N
PubChem CID	5147770
ChemSpider	4321292 Y
Chemical and physical data
Formula	C15H18FNO2
Molar mass	263.307 g/mol
3D model (JSmol)	Interactive image
SMILES CN1C2CC(OC(C3=CC=C(F)C=C3)=O)CC1CC2
InChI InChI=1S/C15H18FNO2/c1-17-12-6-7-13(17)9-14(8-12)19-15(18)10-2-4-11(16)5-3-10/h2-5,12-14H,6-9H2,1H3 Y Key:YXDFSLSXLYAAPF-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

3β-(p-Fluorobenzoyloxy)tropane, (8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoic acid ester, 4-fluorotropacocaine, 3-Pseudotropyl-4-fluorobenzoate, 3-pseudotropyl-4-fluorobenzoate, pFBT) is a tropane derivative drug which acts as a local anaesthetic, having around 30% the stimulant potency of cocaine but around the same potency as a local anaesthetic. It has been investigated as a potential radiolabelled agent for studying receptor binding,^[1] but was not adopted for this application. The main application for fluorotropacocaine, however, has been as a designer drug analogue of cocaine, first detected by the EMCDDA in 2008,^[2][3] and subsequently sold as an ingredient of various "bath salt" powder products, usually mixed in combination with other stimulant drugs such as caffeine, dimethocaine, desoxypipradrol or substituted cathinone derivatives.^[4][5]

See also

• 4′-Fluorococaine
• Tropacocaine

References